Cargando…

A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia

BACKGROUND: Treatment of sickle cell anemia is a challenging task and despite the well understood genetic and biochemical pathway of sickle hemoglobin, current therapy continues to be limited to the symptomatic treatment of pain, supplemental oxygen, antibiotics, red blood cell transfusions and hydr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Misra, Hemant, Bainbridge, James, Berryman, John, Abuchowski, Abraham, Galvez, Kenneth Mauricio, Uribe, Luis Fernando, Hernandez, Angel Luis, Sosa, Nestor Rodolfo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339363/ https://www.ncbi.nlm.nih.gov/pubmed/28270341 http://dx.doi.org/10.1016/j.bjhh.2016.08.004

Ejemplares similares

Effects of Sanguinate on Systemic and Microcirculatory Variables in a Model of Prolonged Hemorrhagic Shock
por: Nugent, William H., et al.
Publicado: (2019)

Case of Sanguineous Apoplexy
por: Abraham, Robert
Publicado: (1825)

On Sanguineous Perspiration
Publicado: (1849)

On the Sanguineous Tumour of the Female Breast
por: Rodman, John
Publicado: (1828)

A sanguine experience: Case Report
por: Aujayeb, Avinash, et al.
Publicado: (2015)

On Simple Sanguineous Cyst of the Ear in Lunatics
por: Stiff, W. Phillimore
Publicado: (1858)

Case of Sanguineous Apoplexy Occurring in a Child
por: Greenhow, T. H.
Publicado: (1822)

On Sanguineous Tumours on the Scalp in New-Born Children
por: Black, Francis
Publicado: (1841)

On Sanguineous Tumours of the Head in New-Born Children
Publicado: (1836)

Risques viraux émergents en transfusion sanguine
por: Pozzetto, B., et al.
Publicado: (2011)

Groupe sanguin ABO et COVID-19
por: Hadj Taieb, Rania, et al.
Publicado: (2021)

Danger of Injections of Perchloride of Iron in Sanguineous Tumors
Publicado: (1869)

Les groupes sanguins des ovins. I. – Relations entre les groupes sanguins des ovins et des bovins
por: Nguyen, Thanh Cac, et al.
Publicado: (1972)

Multifunctional nanosystems: growing sanguinity in siRNA therapy
por: Badrealam, Khan Farheen, et al.
Publicado: (2014)

Passage of Sanguineous Corpuscles through the Walls of the Vessels, Etc.
Publicado: (1868)

Individual Watershed Areas in Sickle Cell Anemia: An Arterial Spin Labeling Study
por: Stotesbury, Hanne, et al.
Publicado: (2022)

Ontogenèse des marqueurs génétiques sanguins chez le cheval
por: Kaminski, Marie, et al.
Publicado: (1974)

Marqueurs génétiques sanguins chez les chevaux de course
por: Podliachouk, Luba, et al.
Publicado: (1975)

Plaquettes sanguines de culture : état de l’art()
por: Strassel, C., et al.
Publicado: (2020)

Sexuality and sickle cell anemia
por: Côbo, Viviane de Almeida, et al.
Publicado: (2013)

Study on the Frequency and Values of Sanguine Eosinophilia in Children Admitted with Parasitary Diseases
por: Singer, Cristina, et al.
Publicado: (2013)

Peculiar Case of an Extensive Sanguineous Tumour, or Extravasation of Blood into the Substance of Thigh
por: Balfour, James B.
Publicado: (1855)

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years
por: Elalfy, Mohsen S., et al.
Publicado: (2022)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
por: Torres, Lidiane de Souza, et al.
Publicado: (2012)

Marqueurs génétiques sanguins chez les chevaux de trait en france
por: Kaminski, Marie, et al.
Publicado: (1976)

PEGylated carboxyhemoglobin bovine (SANGUINATE) ameliorates myocardial infarction in a rat model
por: Kawaguchi, Akira T., et al.
Publicado: (2018)

Oxidative status in sickle cell anemia
por: Magalhães, Silvia Maria Meira
Publicado: (2011)

Hepatobiliary Manifestations of Sickle Cell Anemia
por: Issa, Hussain, et al.
Publicado: (2010)

Sickle Cell Anemia and Babesia Infection
por: Beri, Divya, et al.
Publicado: (2021)

EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia
por: Rankine-Mullings, Angela E, et al.
Publicado: (2016)

Observations and Cases Illustrating the Efficacy of Compressing the Carotid Arteries in Sanguineous Turgescence of the Cerebral Vessels
por: Blaud, M.
Publicado: (1819)

Groupe sanguin ABO et sévérité de la COVID-19 : étude monocentrique
por: Dimassi, Imene, et al.
Publicado: (2021)

Myonecrosis in Sickle Cell Anemia—Overlooked and Underdiagnosed
por: Tageja, Nishant, et al.
Publicado: (2010)

Nitric oxide status in sickle cell anemia
por: Gonçalves, Romélia Pinheiro
Publicado: (2012)

Haplotype Map of Sickle Cell Anemia in Tunisia
por: Moumni, Imen, et al.
Publicado: (2014)

Myonecrosis in Sickle Cell Anemia: Case Study
por: Turaga, Lalita Prabha, et al.
Publicado: (2017)

The clinical epidemiology of sickle cell anemia In Africa
por: Macharia, Alex W., et al.
Publicado: (2017)

An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma
por: De Meulenaere, Astrid, et al.
Publicado: (2021)

Contrasting resting-state fMRI abnormalities from sickle and non-sickle anemia
por: Coloigner, Julie, et al.
Publicado: (2017)

Craniofacial geometric morphometrics in the identification of patients with sickle cell anemia and sickle cell trait
por: Ferreira, Warli de Brito, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c9anfoi96mun54ukkm51hpm9no